Literature DB >> 19433411

The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.

Fina A S Kurreeman1, George N Goulielmos, Behrooz Z Alizadeh, Blanca Rueda, Jeanine Houwing-Duistermaat, Elena Sanchez, Marianna Bevova, Timothy R Radstake, Madelon C Vonk, Emmanouil Galanakis, Norberto Ortego, Willem Verduyn, Maria I Zervou, Bart O Roep, Barbara Dema, Laura Espino, Elena Urcelay, Dimitrios T Boumpas, Leonard H van den Berg, Cisca Wijmenga, Bobby P C Koeleman, Tom W J Huizinga, Rene E M Toes, Javier Martin.   

Abstract

OBJECTIVES: The TRAF1-C5 locus has recently been identified as a genetic risk factor for rheumatoid arthritis (RA). Since genetic risk factors tend to overlap with several autoimmune diseases, a study was undertaken to investigate whether this region is associated with type 1 diabetes (TID), celiac disease (CD), systemic sclerosis (SSc) and systemic lupus erythematosus (SLE).
METHODS: The most consistently associated SNP, rs10818488, was genotyped in a total of 735 patients with T1D, 1049 with CD, 367 with SSc, 746 with SLE and 3494 ethnically- and geographically-matched healthy individuals. The replication sample set consisted of 99 patients with T1D, 272 with SLE and 482 healthy individuals from Crete.
RESULTS: A significant association was detected between the rs10818488 A allele and T1D (OR 1.14, p=0.027) and SLE (OR 1.16, p=0.016), which was replicated in 99 patients with T1D, 272 with SLE and 482 controls from Crete (OR 1.64, p=0.002; OR 1.43, p=0.002, respectively). Joint analysis of all patients with T1D (N=961) and all patients with SLE (N=1018) compared with 3976 healthy individuals yielded an allelic common OR of 1.19 (p=0.002) and 1.22 (p=2.6 x 10(-4)), respectively. However, combining our dataset with the T1D sample set from the WTCCC resulted in a non-significant association (OR 1.06, p=0.087). In contrast, previously unpublished results from the SLEGEN study showed a significant association of the same allele (OR 1.19, p=0.0038) with an overall effect of 1.22 (p=1.02 x 10(-6)) in a total of 1577 patients with SLE and 4215 healthy individuals.
CONCLUSION: A significant association was found for the TRAF1-C5 locus in SLE, implying that this region lies in a pathway relevant to multiple autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433411     DOI: 10.1136/ard.2008.106567

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

Review 1.  Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

Authors:  A M Mohamed Thoufic Ali; S Vino
Journal:  Rheumatol Int       Date:  2016-09-16       Impact factor: 2.631

Review 2.  Pathways: Strategies for susceptibility genes in SLE.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Autoimmun Rev       Date:  2010-02-08       Impact factor: 9.754

3.  Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.

Authors:  Anna Missiou; Natascha Köstlin; Nerea Varo; Philipp Rudolf; Peter Aichele; Sandra Ernst; Christian Münkel; Carina Walter; Peter Stachon; Benjamin Sommer; Dietmar Pfeifer; Katja Zirlik; Lindsey MacFarlane; Dennis Wolf; Erdyni Tsitsikov; Christoph Bode; Peter Libby; Andreas Zirlik
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

4.  TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies.

Authors:  Jessica A B van Nies; Rute B Marques; Stella Trompet; Zuzana de Jong; Fina A S Kurreeman; Rene E M Toes; J Wouter Jukema; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2010-03-05       Impact factor: 5.156

5.  Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.

Authors:  Xu-jie Zhou; Xiao-lan Lu; Swapan K Nath; Ji-cheng Lv; Sai-nan Zhu; Hai-zhen Yang; Lian-xiang Qin; Ming-hui Zhao; Yin Su; Nan Shen; Zhan-guo Li; Hong Zhang
Journal:  Arthritis Rheum       Date:  2012-01

6.  Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.

Authors:  Mai Tuyet Vuong; Iva Gunnarsson; Sigrid Lundberg; Elisabet Svenungsson; Lars Wramner; Anders Fernström; Ann-Christine Syvänen; Lieu Thi Do; Stefan H Jacobson; Leonid Padyukov
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

Review 7.  Novel mechanisms of action of the biologicals in rheumatic diseases.

Authors:  Cecilia Beatrice Chighizola; Ennio Giulio Favalli; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

8.  A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis.

Authors:  Stefan Wieczorek; Julia U Holle; Stephanie Müller; Harald Fricke; Wolfgang L Gross; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

9.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

Review 10.  Structural feature of TRAFs, their related human diseases and therapeutic intervention.

Authors:  Hyun Ho Park
Journal:  Arch Pharm Res       Date:  2021-05-10       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.